fluoxetine has been researched along with meperidine in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (11.11) | 18.7374 |
| 1990's | 1 (11.11) | 18.2507 |
| 2000's | 3 (33.33) | 29.6817 |
| 2010's | 4 (44.44) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Topliss, JG; Yoshida, F | 1 |
| Nagashima, R; Nishikawa, T; Tobita, M | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Sen, S; Sinha, N | 1 |
| Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Leander, JD; McCleary, P | 1 |
| Pasco, J | 1 |
| Tissot, TA | 1 |
1 review(s) available for fluoxetine and meperidine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
8 other study(ies) available for fluoxetine and meperidine
| Article | Year |
|---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
A discriminant model constructed by the support vector machine method for HERG potassium channel inhibitors.
Topics: Animals; CHO Cells; Cricetinae; Discriminant Analysis; ERG1 Potassium Channel; Ether-A-Go-Go Potassium Channels; Humans; Potassium Channel Blockers; Potassium Channels, Voltage-Gated | 2005 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Predicting hERG activities of compounds from their 3D structures: development and evaluation of a global descriptors based QSAR model.
Topics: Computer Simulation; Ether-A-Go-Go Potassium Channels; Humans; Molecular Structure; Organic Chemicals; Quantitative Structure-Activity Relationship | 2011 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |
Meperidine-induced hypothermia in the rat.
Topics: 5-Hydroxytryptophan; Animals; Body Temperature; Drug Interactions; Female; Fluoxetine; Meperidine; Morphine; Rats; Rats, Inbred Strains; Time Factors | 1982 |
Emergency medicine. Is this a drug reaction?
Topics: Adult; Analgesics, Opioid; Biliary Tract Diseases; Colic; Depression, Postpartum; Diagnosis, Differential; Dopamine Antagonists; Drug Hypersensitivity; Drug Interactions; Drug Therapy, Combination; Emergency Medicine; Female; Fluoxetine; Humans; Meperidine; Metoclopramide; Muscle Weakness; Selective Serotonin Reuptake Inhibitors; Shivering; Sweating | 1998 |
Probable meperidine-induced serotonin syndrome in a patient with a history of fluoxetine use.
Topics: Adult; Analgesics, Opioid; Cholangiopancreatography, Endoscopic Retrograde; Diabetes Mellitus, Type 2; Drug Interactions; Fluoxetine; Humans; Male; Meperidine; Pancreatitis; Selective Serotonin Reuptake Inhibitors; Serotonin Syndrome | 2003 |